http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011218634-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 |
| filingDate | 2011-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51e59c45237ca74a1a07dbfab01ca48f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4080f5f35891b99c3bec551bf0e653c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_394c6f451e402b44179f9e185ebad702 |
| publicationDate | 2011-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2011218634-A1 |
| titleOfInvention | Infant formulas containing docosahexaenoic acid and lutein |
| abstract | INFANT FORMULAS CONTAINING DOCOSAHEXANEOIC ACID AND LUTEIN Abstract Disclosed are infant formulas and corresponding methods of using them to promote 5 retinal health and vision development in infants. The formulas, which are free of egg phospholipids and comprise fat, protein, carbohydrate, vitamins, and minerals, including docosahexaenoic acid and, on a ready-to-feed basis, at least about 50 mcg/liter of lutein, wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1. The formulas are also believed to be especially useful in reducing the risk 10 of retinopathy of prematurity in preterm infants. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11696920-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018083271-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110198706-A |
| priorityDate | 2005-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.